Soluplus-stabilized 5-fluorouracil-entrapped niosomal formulations prepared via active and passive loading techniques: comparative physico-chemical evaluation

References

• Bhardwaj, P.; Tripathi, P.; Gupta, R.; Pandey, S. Niosomes : A Review on Niosomal Research in the Last Decade. J. Drug Delivery Sci. Technol. 2020, 56, 101581. DOI: 10.1016/j.jddst.2020.101581.
   Web of Science ®Google Scholar
• Khan, R.; Irchhaiya, R. An Overview on Niosomes as Efficient Drug Carriers. Int. J. PharmBio. Sci. 2017, 8, 106–116.
   PubMedGoogle Scholar
• Kumar, G. P.; Rajeshwarrao, P. Nonionic Surfactant Vesicular Systems for Effective Drug Delivery—an Overview. Acta Pharmaceut. Sin. B 2011, 1, 208–219. DOI: 10.1016/j.apsb.2011.09.002.
   Web of Science ®Google Scholar
• Durak, S.; Rad, M. E.; Yetisgin, A. A.; Sutova, H. E.; Kutlu, O.; Cetinel, S.; Zarrabi, A. Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects. Nanomaterials 2020, 10, 1–29. DOI: 10.3390/nano10061191.
   Web of Science ®Google Scholar
• Sankhyan, A.; Pawar, P. Recent Trends in Niosome as Vesicular Drug Delivery System. J. Appl. Pharm. Sci. 2012, 02, 20–32.
   Google Scholar
• Dehaghi, M. H.; Haeri, A.; Keshvari, H.; Abbasian, Z.; Dadashzadeh, S. Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods. Iran J. Pharm. Res. 2017, 16, 413–422.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J.; Taymouri, S.; Pardakhty, A.; Asadi-Shekaari, M.; Babaee, A. Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats. Biomed. Res. Int. 2014, 2014, 1–10. DOI: 10.1155/2014/816103.
   Web of Science ®Google Scholar
• Moghassemi, S.; Hadjizadeh, A. Nano-Niosomes as Nanoscale Drug Delivery Systems: An Illustrated Review. J. Control Release 2014, 185, 22–36. DOI: 10.1016/j.jconrel.2014.04.015.
   PubMed Web of Science ®Google Scholar
• Tuomela, A.; Hirvonen, J.; Peltonen, L. Stabilizing Agents for Drug Nanocrystals : Effect on Bioavailability. Pharmaceutics 2016, 8 (16),1–18. DOI: 10.3390/pharmaceutics8020016.
   Google Scholar
• Kim, M. Soluplus-Coated Colloidal Silica Nanomatrix System for Enhanced Supersaturation and Oral Absorption of Poorly Water-Soluble Drugs. Artif. Cells Nanomed. Biotechnol. 2013, 41, 363–367.
   PubMed Web of Science ®Google Scholar
• Yang, H.; Teng, F.; Wang, P.; Tian, B.; Lin, X.; Hu, X.; Zhang, L.; Zhang, A.; Zhang, Y.; Tang, X. Investigation of a Nanosuspension Stabilized by Soluplus 1 to Improve Bioavailability. Int. J. Pharm. 2014, 477, 88–95. DOI: 10.1016/j.ijpharm.2014.10.025.
   PubMed Web of Science ®Google Scholar
• Longley, D. B.; Harkin, D. P.; Johnston, P. G. 5-Fluorouracil: Mechanisms of Action and Clinical Strategies. Nat. Rev. Cancer 2003, 3, 330–338. DOI: 10.1038/nrc1074.
   PubMed Web of Science ®Google Scholar
• Udofot, O.; Affram, K.; Smith, T.; Tshabe, B.; Krishnan, S.; Sachdeva, M.; Agyare, E. Pharmacokinetic, Biodistribution and Therapeutic Efficacy of 5fluorouracil-Loaded pH-Sensitive PEGylated Liposomal Nanoparticles in HCT-116 Tumor Bearing Mouse. J. Nat. Sci. 2016, 2, e171.
   PubMedGoogle Scholar
• Zhang, H. Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation. In Liposomes Methods in Molecular Biology, Vol. 1522; DG, editor; Humana Press: New York, 2017.
   Google Scholar
• Gong, W. J.; Nadzir, W. M.; Hisham, S. F.; Kalidas, S. R. Size, Entrapment Efficiency and Stability of Curcumin Niosomes Prepared at Different pH Conditions. Asian J. Sci. Res. 2020, 13, 23–28. DOI: 10.3923/ajsr.2020.23.28.
   Google Scholar
• Yassin, A. E. B.; Anwer, M. K.; Mowafy, H. A.; El-Bagory, I. M.; Bayomi, M. A.; Alsarra, I. A. Optimization of 5-Flurouracil Solid-Lipid Nanoparticles : A Preliminary Study to Treat Colon Cancer. Int. J. Med. Sci. 2010, 7, 398–408. DOI: 10.7150/ijms.7.398.
   PubMed Web of Science ®Google Scholar
• Ruckmani, K.; Sankar, V. Formulation and Optimization of Zidovudine Niosomes. AAPS PharmSciTech 2010, 11, 1119–1127. DOI: 10.1208/s12249-010-9480-2.
   PubMed Web of Science ®Google Scholar
• Patel, K.; Sarma, V.; Vavia, P. Design and Evaluation of Lumefantrine - Oleic Acid Self Nanoemulsifying Ionic Complex for Enhanced Dissolution. DARU, J. Pharm. Sci. 2013, 21, 1–11.
   Web of Science ®Google Scholar
• Taymouri, S.; Varshosaz, J. Effect of Different Types of Surfactants on the Physical Properties and Stability of Carvedilol Nano-Niosomes. Adv. Biomed. Res. 2016, 5, 48. DOI: 10.4103/2277-9175.178781.
   PubMedGoogle Scholar
• Mateos, H.; Gentile, L.; Murgia, S.; Colafemmina, G.; Collu, M.; Smets, J.; Palazzo, G. Understanding the Self-Assembly of the Polymeric Drug Solubilizer Soluplus®. J. Colloid Interface Sci. 2022, 611, 224–234. DOI: 10.1016/j.jcis.2021.12.016.
   PubMed Web of Science ®Google Scholar
• Mohamed, H. B.; El-Shanawany, S. M.; Hamad, M. A.; Elsabahy, M. Niosomes: A Strategy toward Prevention of Clinically Significant Drug Incompatibilities. Sci. Rep. 2017, 7, 1–14. DOI: 10.1038/s41598-017-06955-w.
   PubMed Web of Science ®Google Scholar
• Danaei, M.; Dehghankhold, M.; Ataei, S.; Hasanzadeh, D. F.; Javanmard, R.; Dokhani, A.; Mozafari, M. R. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 2018, 10, 57. DOI: 10.3390/pharmaceutics10020057.
   PubMed Web of Science ®Google Scholar
• Obitte, N. C.; Ofokansi, K. C.; Kenechukwu, F. C. Development and Evaluation of Novel Self-Nanoemulsifying Drug Delivery Systems Based on a Homolipid from Capra Hircus and Its Admixtures with Melon Oil for the Delivery of Indomethacin. J. Pharm. 2014, 2014, 1–9. DOI: 10.1155/2014/340486.
   Google Scholar
• Attia, M. F.; Anton, N.; Wallyn, J.; Omran, Z.; Vandamme, T. F. An Overview of Active and Passive Targeting Strategies to Improve the Nanocarriers Efficiency to Tumour Sites an Overview of Active and Passive Targeting Strategies to Improve the Nanocarriers Efficiency to Tumour Sites. J. Pharm. Pharmacol. 2019, 71, 1185–1198. DOI: 10.1111/jphp.13098.
   PubMed Web of Science ®Google Scholar
• Agarwal, S.; Bakshi, V.; Vitta, P.; Raguram, A. P.; Pandey, S.; Udupa, N. Effect of Cholesterol Content and Surfactant HLB on Vesicle Properties of Niosomes. IJPS 2004, 66, 121–122.
   Google Scholar
• Lu, B.; Huang, Y.; Chen, Z.; Ye, J.; Xu, H.; Chen, W.; Long, X. Niosomal Nanocarriers for Enhanced Skin Delivery of Quercetin with Functions of anti-Tyrosinase and Antioxidant. Molecules 2019, 24, 2322. DOI: 10.3390/molecules24122322.
   PubMed Web of Science ®Google Scholar
• Kenechukwu, F. C.; Kalu, C. F.; Momoh, M. A.; Onah, I. A.; Attama, A. A.; Okore, V. Novel Bos Indicus Fat-Based Nanoparticulate Lipospheres of Miconazole Nitrate as Enhanced Mucoadhesive Therapy for Oral Candidiasis. Biointerface Res. Appl. Chem. 2021, 13, 1–19.
   Web of Science ®Google Scholar
• Elkhatib, M. M.; Ali, A. I.; Abdelrazek, S. A.; Al-Badrawy, A. Pre-Formulation Study on 5-Fluorouracil and Certain Lipids for Solid Lipid Nanoparticles Preparation. Int. J. Appl. Pharm. 2022, 14, 160–171. DOI: 10.22159/ijap.2022v14i2.43491.
   PubMedGoogle Scholar
• Ugorji, O. L.; Umeh, O. N. C.; Agubata, C. O.; Adah, D.; Obitte, N. C.; Chukwu, A. The Effect of Noisome Preparation Methods in Encapsulating 5-Fluorouracil and Real Time Cell Assay against HCT-116 Colon Cancer Cell Line. Heliyon 2022, e12369, 1–13. DOI: 10.1016/j.heliyon.2022.e12369.
   Google Scholar
• Anbarasan, B.; Rekha, S.; Elango, K.; Shriya, B.; Ramaprabhu, S. Optimization of the Formulation and in-Vitro Evaluation of Capecitabine Niosomes for the Treatment of Colon Cancer. Int. J. Pharm. Sci. Res. 2013, 1504–1513.
   Google Scholar
• Angelova, M. I.; Bitbol, A. F.; Seigneuret, M.; Staneva, G.; Kodama, A.; Sakuma, Y.; Kawakatsu, T.; Imai, M.; Puff, N. pH Sensing by Lipids in Membranes: The Fundamentals of pH-Driven Migration, Polarization and Deformations of Lipid Bilayer Assemblies. Biochim. Biophys. Acta Biomembr. 2018, 1860, 2042–2063. DOI: 10.1016/j.bbamem.2018.02.026.
   PubMed Web of Science ®Google Scholar
• Asthana, G. S.; Sharma, P. K.; Asthana, A. In Vitro and in Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin. Scientifica 2016, 2016, 1–10. DOI: 10.1155/2016/6492953.
   Google Scholar
• Pignatello, R.; Corsaro, R.; Bonaccorso, A.; Zingale, E.; Carbone, C.; Musumeci, T. Soluplus® Polymeric Nanomicelles Improve Solubility of BCS-Class II Drugs. Drug Deliv. Transl. Res. 2022, 12, 1991–2006.
   PubMed Web of Science ®Google Scholar
• Naelapää, K.; Boetker, J.; Müllertz, A.; Rades, T.; Rantanen, J.; Bar-Shalom, D. Soluplus® for Modifying the Release of Highly Water Soluble APIs. Presented at the 2nd Electronic Conference on Pharmaceutical Sciences 2012, p. 824. DOI: 10.3390/ecps2012-00824.
   Google Scholar
• Gubernator, J. Active Methods of Drug Loading into Liposomes: Recent Strategies for Stable Drug Entrapment and Increased in Vivo Activity. Expert Opin. Drug Deliv. 2011, 8, 565–580. DOI: 10.1517/17425247.2011.566552.
   PubMed Web of Science ®Google Scholar
• Pauli, G.; Tang, W.; Li, S. Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds. Pharmaceutics 2019, 11, 465. DOI: 10.3390/pharmaceutics11090465.
   PubMed Web of Science ®Google Scholar